Related Experiment Video
Updated: May 17, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Multistate fungal meningitis outbreak -- interim guidance for treatment
Abstract:
CDC and the Food and Drug Administration (FDA) continue to work closely with state and local public health departments on the multistate meningitis outbreak investigation of fungal infections among patients who received a steroid injection of a potentially contaminated product into the spinal area. The investigation also includes possible fungal infections associated with injections in a peripheral joint space. These cases are associated with a potentially contaminated steroid medication prepared by New England Compounding Center (NECC) in Framingham, Massachusetts.
Insights
Fungal meningitis outbreaks linked to contaminated steroid injections from New England Compounding Center (NECC) are under investigation by the CDC and FDA. Public health departments are involved in tracking these serious fungal infections.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- A multistate outbreak of fungal infections, including meningitis, has been identified.
- Cases are associated with patients receiving steroid injections, primarily into the spinal area.
- The suspected source is a potentially contaminated steroid medication.
Purpose of the Study:
- To investigate the cause and scope of the multistate fungal infection outbreak.
- To identify the specific contaminated product and its source.
- To coordinate public health response efforts.
Main Methods:
- Collaboration between the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA).
- Close work with state and local public health departments.
- Investigation into fungal infections linked to spinal and peripheral joint injections.
Main Results:
- Identification of a potentially contaminated steroid medication as the source.
- The medication was prepared by New England Compounding Center (NECC).
- The outbreak involves serious fungal infections, including meningitis.
Conclusions:
- The investigation highlights the risks associated with compounded medications.
- Public health agencies are actively working to contain the outbreak.
- Continued surveillance and response are crucial to prevent further infections.
Related Concept Videos
Fungal Phylum Microsporidia
Antifungal Agents
Bacterial Meningitis I: Introduction
Pharmaceutical Poisoning: Treatment Strategies
Endocarditis III: Medical Management
Viral Meningitis
